WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO aims at promoting scientific excellence in fundamental life sciences research and translating scientific achievements in medical, pharmaceutical and veterinary biotechnology applications.
NEWS
2nd call for projects.
On 27th February 2012, WELBIO launched its 2nd call for projects in fundamental research in life sciences in domains that may lead to medical, pharmaceutical and/or veterinary biotechnology applications. The call is now closed. For applicants who submitted a letter of intent, the deadline for project submission is 30th May 2012. Read more...
Emile Van Schaftingen (UCL) is the recipient of the 2011-2012 Chaire Francqui.
15/02/2012 – This cycle of conferences will focus on intermediate metabolism in the post-genomic era and will take place at the Facultés Universitaires Notre-Dame de la Paix de Namur. Read more...
A new role for Vascular Endothelial Growth Factor (VEGF) in regulating skin cancer stem cells.
19/10/2011 - In a study published in Nature, researchers identify a new role for Vascular Endothelial Growth Factor (VEGF) in regulating skin cancer stem cells. The study was lead by Cédric Blanpain, WELBIO investigator at Université Libre de Bruxelles, in collaboration with the groups of Peter Carmeliet (VIB/K.U.Leuven) and Jody J. Haigh (VIB/UGent). The results can have important implications for the prevention and treatment of different epithelial cancers. Read more...
All news
Français